AIMS: Cryoballoon ablation (CBA) is a well-used technique when performing pulmonary vein (PV) isolation in patients with paroxysmal atrial fibrillation (AF). Our aim is to describe incidence, characteristics, and clinical predictors for developing atrial tachycardias (ATs) after cryoballoon PV isolation in patients with paroxysmal AF. METHODS AND RESULTS: The study population consisted of 181 consecutive patients undergoing a first CBA. All patients received an event-recorder before cryoablation and transmitted daily electrocardiogram (ECG) during 1 month before ablation and 3 months after. Further follow-up consisted of 24 h Holter monitoring and ECG registration every 3 months and also in patients presenting with symptoms. A mean follow-up period was 497.9 ± 283.9 days, and 175 patients completed follow-up. In 14 (8%) patients regular ATs were registered. In multivariate logistic regression model, the following parameters were independently associated with ATs after ablation: an additional right PV, treatment with beta-blockers, and presence of AT on event-recording strips before ablation. Seven (4%) patients with registered AT underwent a redo procedure. In two (1.1%) patients ATs were originated in reconnected PVs. In other patients no left AT was induced. No macro re-entrant left AT was documented in any patient. During follow-up, after a redo ablation, no AT was registered. CONCLUSION: The incidence of left AT after CBA is low, and no left atrial macro re-entrant tachycardia was found. The following independent predictors of AT development have been identified: an additional right PV, regular AT registered before ablation, and the use of beta-blockers.
AIMS: Cryoballoon ablation (CBA) is a well-used technique when performing pulmonary vein (PV) isolation in patients with paroxysmal atrial fibrillation (AF). Our aim is to describe incidence, characteristics, and clinical predictors for developing atrial tachycardias (ATs) after cryoballoon PV isolation in patients with paroxysmal AF. METHODS AND RESULTS: The study population consisted of 181 consecutive patients undergoing a first CBA. All patients received an event-recorder before cryoablation and transmitted daily electrocardiogram (ECG) during 1 month before ablation and 3 months after. Further follow-up consisted of 24 h Holter monitoring and ECG registration every 3 months and also in patients presenting with symptoms. A mean follow-up period was 497.9 ± 283.9 days, and 175 patients completed follow-up. In 14 (8%) patients regular ATs were registered. In multivariate logistic regression model, the following parameters were independently associated with ATs after ablation: an additional right PV, treatment with beta-blockers, and presence of AT on event-recording strips before ablation. Seven (4%) patients with registered AT underwent a redo procedure. In two (1.1%) patients ATs were originated in reconnected PVs. In other patients no left AT was induced. No macro re-entrant left AT was documented in any patient. During follow-up, after a redo ablation, no AT was registered. CONCLUSION: The incidence of left AT after CBA is low, and no left atrial macro re-entrant tachycardia was found. The following independent predictors of AT development have been identified: an additional right PV, regular AT registered before ablation, and the use of beta-blockers.
Authors: Jayson R Baman; Rachel M Kaplan; Celso L Diaz; Graham Peigh; Aakash A Bavishi; Amar Trivedi; Jeremiah Wasserlauf; Alexandru B Chicos; Rishi Arora; Susan Kim; Albert Lin; Nishant Verma; Bradley P Knight; Rod S Passman Journal: J Interv Card Electrophysiol Date: 2019-05-17 Impact factor: 1.900
Authors: Esra Gucuk Ipek; Joseph E Marine; Mohammadali Habibi; Jonathan Chrispin; Joao Lima; Jack Rickard; David Spragg; Stefan L Zimmerman; Vadim Zipunnikov; Ronald Berger; Hugh Calkins; Saman Nazarian Journal: Heart Rhythm Date: 2015-09-28 Impact factor: 6.343
Authors: Patrick Leitz; Kristina Wasmer; Christian Andresen; Fatih Güner; Julia Köbe; Benjamin Rath; Florian Reinke; Julian Wolfes; Philipp S Lange; Christian Ellermann; Gerrit Frommeyer; Lars Eckardt Journal: J Cardiovasc Dev Dis Date: 2022-02-03
Authors: Alvise Del Monte; Luigi Pannone; Antonio Bisignani; Thiago G Osório; Saverio Iacopino; Gian-Battista Chierchia; Carlo de Asmundis Journal: Front Cardiovasc Med Date: 2022-07-28
Authors: Evgeny N Mikhaylov; Dmitry S Lebedev; Evgeny A Pokushalov; Karapet V Davtyan; Eduard A Ivanitskii; Anatoly A Nechepurenko; Alexey Ya Kosonogov; Grigory V Kolunin; Igor A Morozov; Sergey A Termosesov; Evgeny B Maykov; Dmitry N Khomutinin; Sergey A Eremin; Igor M Mayorov; Alexander B Romanov; Vitaliy V Shabanov; Victoria Shatakhtsyan; Viktor Tsivkovskii; Amiran Sh Revishvili; Evgeny V Shlyakhto Journal: Biomed Res Int Date: 2015-11-12 Impact factor: 3.411